John B. Rhodes, Director at Tonix Pharmaceuticals Holding Corp. (TNXP), bought 25,000 shares at $2.00 ($50K) on 2016-06-21, disclosed to the SEC on 2016-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |